Product Code: GVR-4-68040-501-7
Bone Punches Market Size & Trends:
The global bone punches market size was valued at USD 198.30 million in 2024 and is anticipated to grow at a CAGR of 4.13% from 2025 to 2030. The rising prevalence of bone disorders such as arthritis, osteoporosis, and fractures is driving the need for surgical interventions. Bone punches are crucial in orthopedic surgeries, which are more common as these conditions rise. The demand for orthopedic surgeries is increasing globally, fueled by the aging population, sports injuries, and accidents. As joint replacements and spinal surgeries become more frequent, the need for bone punches in these procedures grows.
As the global population ages, there is a growing demand for orthopedic surgeries and treatments. Bone Punches are commonly used in orthopedic procedures such as fracture repair and joint replacement surgeries. The prevalence of bone-related diseases such as osteoporosis, arthritis, and fractures is growing, which directly drives the demand for orthopedic surgical tools, including bone punches. As per WHO, by 2030, 1 in 6 people worldwide will be aged 60 years or over.
With surgeries becoming increasingly complex, there is a heightened demand for instruments that can ensure precision and reduce complications. Bone Punches are integral to such operations, as they are designed to precisely remove or reshape bone tissue. Surgeons and healthcare providers are increasingly using high-quality tools that can lead to better patient outcomes, which contributes to the growth in the bone punches market. The rising number of orthopedic surgeries, driven by increased accidents, sports injuries, and degenerative diseases, has spurred the demand for bone punches. Accidents and trauma-related injuries, which require the removal or manipulation of bone tissue, increase the need for reliable surgical tools, further boosting the demand for bone punches.
The growth of healthcare infrastructure, particularly in emerging markets, has increased the availability of specialized surgeries, thus driving demand for Bone Punches. Hospitals and clinics in both developed and developing regions are adopting advanced surgical tools to meet patient needs. Government and private healthcare spending are increasing globally, leading to more significant investment in medical equipment and surgical tools, including Bone Punches. The increasing emphasis on regulatory approval, including from entities such as the FDA, ensures that bone punches meet safety and performance standards. These regulations help drive the adoption of high-quality instruments, as hospitals prefer to use certified tools that reduce risks. Across different markets, adherence to international health and safety standards in medical devices encourages the adoption of advanced bone punches, as healthcare facilities aim to ensure patient safety.
Global Bone Punches Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels, and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global bone punches market report on the basis of product type, application, end use, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Classical Kerrison
- Detachable Kerrison
- Noir Kerrison
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Orthopedic Surgeries
- Spinal Surgeries
- Dental Surgeries
- Craniofacial Surgeries
- Other Applications
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Research and Academic Institutes
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Bone Punches Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Prevalence of Orthopedic and Spinal Disorders
- 3.2.1.2. Aging Population
- 3.2.1.3. Rise in Minimally Invasive Procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Cost of Surgical Instruments
- 3.2.2.2. Stringent Regulatory Standards
- 3.3. Bone Punches Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Bone Punches Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 4.1. Bone Punches Market: Product Outlook and Key Takeaways
- 4.2. Bone Punches Market: Product Movement Analysis
- 4.3. Bone Punches Market Estimates & Forecast, by Product (USD Million)
- 4.4. Classical Kerrison
- 4.4.1. Classical Kerrison Market, 2018 - 2030 (USD Million)
- 4.5. Detachable Kerrison
- 4.5.1. Detachable Kerrison Market, 2018 - 2030 (USD Million)
- 4.6. Noir Kerrison
- 4.6.1. Noir Kerrison Market, 2018 - 2030 (USD Million)
Chapter 5. Bone Punches Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 5.1. Bone Punches Market: Application Outlook and Key Takeaways
- 5.2. Bone Punches Market: Application Movement Analysis
- 5.3. Bone Punches Market Estimates & Forecast, by Application (USD Million)
- 5.4. Orthopedic Surgeries
- 5.4.1. Orthopedic Surgeries Market, 2018 - 2030 (USD Million)
- 5.5. Spinal Surgeries
- 5.5.1. Spinal Surgeries Market, 2018 - 2030 (USD Million)
- 5.6. Dental Surgeries
- 5.6.1. Dental Surgeries Market, 2018 - 2030 (USD Million)
- 5.7. Craniofacial Surgeries
- 5.7.1. Craniofacial Surgeries Market, 2018 - 2030 (USD Million)
- 5.8. Other Applications
- 5.8.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 6. Bone Punches Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)
- 6.1. Bone Punches Market: End Use Outlook and Key Takeaways
- 6.2. Bone Punches Market: End Use Movement Analysis
- 6.3. Bone Punches Market Estimates & Forecast, by End Use (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
- 6.5. Ambulatory Surgical Centers (ASCs)
- 6.5.1. Ambulatory Surgical Centers (ASCs) Market, 2018 - 2030 (USD Million)
- 6.6. Specialty Clinics
- 6.6.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
- 6.7. Research and Academic Institutes
- 6.7.1. Research and Academic Institutes Market, 2018 - 2030 (USD Million
Chapter 7. Bone Punches Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework/ reimbursement structure
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework/ reimbursement structure
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Recent Developments & Impact Analysis by Key Market Participants
- 8.3. Company Market Share Analysis, 2024
- 8.4. Key Company Profiles
- 8.4.1. Acumed, LLC
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Aesculap, Inc. (by B. Braun Company)
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Arthrex, Inc.
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. BD
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. CONMED Corporation
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Exactech, Inc.
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. G Source, Inc.
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Innomed, Inc.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Integra LifeSciences Holdings Corp.
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Johnson & Johnson Services, Inc.
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives